skip to Main Content

Perioperative Chemotherapy Feasible for Resectable Pancreatic Adenocarcinoma

Perioperative Chemotherapy Feasible for Resectable Pancreatic Adenocarcinoma
Perioperative chemotherapy appeared feasible for patients with resectable pancreatic adenocarcinoma, according to randomized phase 2 study results presented at ASCO Annual Meeting.

Safety results and resection rates also appeared encouraging, Davendra P.S. Sohal, MD, MPH, gastrointestinal medical oncologist and director of the clinical genomics program at Cleveland Clinic Taussig Cancer Institute, and colleagues concluded. Read more . . .


Back To Top